GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Accumulated other comprehensive income (loss)

GENinCode (LSE:GENI) Accumulated other comprehensive income (loss) : £0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GENinCode Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. GENinCode's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was £0.00 Mil.

GENinCode Accumulated other comprehensive income (loss) Historical Data

The historical data trend for GENinCode's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Accumulated other comprehensive income (loss) Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial - - - - -

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

GENinCode Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

GENinCode Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of GENinCode's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

GENinCode Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
LSE:VRCI LSE:OBD LSE:GDR LSE:LLAI LSE:PRM LSE:ABDX TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX XPAR:BIM ILMN
Traded in Other Exchanges
9PL:Germany
Address
Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
Website
https://www.genincode.com
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.